| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/26/2013 | US8404710 Phosphodiesterase 10A inhibitor |
| 03/26/2013 | US8404676 Oxadiazole diaryl compounds |
| 03/26/2013 | US8404226 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 03/26/2013 | CA2474424C Salts of valsartan |
| 03/26/2013 | CA2463850C Remodeling of tissues and organs |
| 03/26/2013 | CA2457925C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 03/26/2013 | CA2395197C Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 03/26/2013 | CA2312000C Mammalian cytokine-like polypeptide-10 |
| 03/21/2013 | WO2013039202A1 Novel acrylic acid derivative |
| 03/21/2013 | WO2013039187A1 Guanidinobenzoic acid compound |
| 03/21/2013 | WO2013039140A1 Fused heterocyclic derivative |
| 03/21/2013 | WO2013039057A1 Pyrrolidine-3-ylacetic acid derivative |
| 03/21/2013 | US20130072667 Use of rgm and its modulators |
| 03/21/2013 | US20130072570 Interomone Compositions and Their Use to Modify Behavior in Different Vertebrate Species |
| 03/21/2013 | US20130072550 PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPalpha SECRETION AND IMROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS |
| 03/21/2013 | US20130072517 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 03/21/2013 | US20130072493 N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS |
| 03/21/2013 | US20130072480 Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators |
| 03/21/2013 | US20130072455 Methods and Compositions for Treating Ectoparasite Infestation |
| 03/21/2013 | US20130072435 Tribonectins |
| 03/21/2013 | US20130071407 Methods for modulating hematopoiesis and vascular growth |
| 03/21/2013 | US20130071332 Labeled molecular imaging agents and methods of use |
| 03/21/2013 | CA2848561A1 Guanidinobenzoic acid compound |
| 03/21/2013 | CA2844617A1 Pyrrolidine-3-ylacetic acid derivative |
| 03/20/2013 | EP2570478A1 Reducing agent from microorganism belonging to genus bacillus and application for same |
| 03/20/2013 | EP2570403A1 Urea compounds and use thereof for inhibiting apoptosis |
| 03/20/2013 | CN1606554B Beta-lactamyl vasopressin v1a antagonists |
| 03/20/2013 | CN1541107B Growth factor complex |
| 03/20/2013 | CN1441841B Stimulation of cellular regeneration and differentiation in inner ear |
| 03/20/2013 | CN102985405A Heterocyclic compound, and p27 kip1 degradation inhibitor |
| 03/20/2013 | CN102985112A Pharmaceutical composition for treatment and prevention of herpesvirus infections |
| 03/20/2013 | CN102977016A Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
| 03/20/2013 | CN102973911A Medicine used for relieving narcotic |
| 03/20/2013 | CN102973830A Method for extracting flavonoid from asparagus |
| 03/20/2013 | CN102973740A Blood activating and stasis removing pharmaceutical preparation |
| 03/20/2013 | CN102973723A Traditional Chinese medicine formulas for prevention and treatment of koi diseases |
| 03/20/2013 | CN102973697A Traditional Chinese medicine composition particles for clearing heat and expelling damp, and preparation method thereof |
| 03/20/2013 | CN102178699B Preparation for enhancing human immunity and promoting growth and development |
| 03/20/2013 | CN102134558B Bacillussubtilis and application thereof in raising Apostichopus japonicus |
| 03/20/2013 | CN102133388B Preparation process of placebo prepared by traditional Chinese medicine |
| 03/20/2013 | CN101843653B Processing method of Chinese stellera root condensed decoction |
| 03/20/2013 | CN101687819B Novel preparation for external use |
| 03/20/2013 | CN101674841B Anti-histamine substance and method for production thereof |
| 03/20/2013 | CN101585792B Preparation method of a piglet intestinal canal barrier function controlling substance -N-acetylcysteine |
| 03/20/2013 | CN101384266B Fixed-dose association of phytate and zinc |
| 03/19/2013 | US8399667 4-anilino quinazoline derivatives as antiproliferative agents |
| 03/19/2013 | US8399617 Non-functional P2X7 receptor |
| 03/19/2013 | US8399520 Selective estrogen receptor modulator |
| 03/19/2013 | US8399414 Analgesics |
| 03/19/2013 | US8399016 Sustained-release tablet composition of pramipexole |
| 03/19/2013 | US8398990 Glucan-based vaccines |
| 03/19/2013 | US8398984 Removal promoters and inhibitor for apoptosis cells in vivo |
| 03/19/2013 | CA2538960C Cinnamoyl compound and use of the same |
| 03/19/2013 | CA2488499C Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"),combinations thereof as well as manufacturing of these pharmaceutical compositions |
| 03/19/2013 | CA2429342C Promoters exhibiting endothelial cell specificity and methods of using same |
| 03/19/2013 | CA2354638C Expression of secreted human alpha-fetoprotein in transgenic animals |
| 03/14/2013 | WO2013036974A1 Cellular uptake control systems |
| 03/14/2013 | WO2013035943A1 Betulinic acid having anti-aging activity and derivatives thereof, and composition containing same |
| 03/14/2013 | WO2013035833A1 Morphinan derivative |
| 03/14/2013 | WO2013035827A1 Novel olefin derivative |
| 03/14/2013 | WO2013035826A1 Fused heterocyclic compound |
| 03/14/2013 | WO2013035209A1 Method of applying etfb to abnormal proliferation of cell, and abnormal proliferation inhibitor |
| 03/14/2013 | WO2013034292A1 Pharmaceutical compositions containing carboxylated starch |
| 03/14/2013 | WO2013033862A1 4-substituted-(3-substituted-1h-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof |
| 03/14/2013 | US20130066069 Processes for preparing substituted pyrimidines |
| 03/14/2013 | US20130065962 Compounds For Use In The Treatment Of Diseases |
| 03/14/2013 | US20130065838 Sap variants and their use |
| 03/14/2013 | US20130064892 Cellulosic gel material as a pharmaceutical excipient |
| 03/14/2013 | US20130064888 Pharmaceutical formulations |
| 03/14/2013 | US20130064760 Method for Treating Crohn's Disease By Administering An Anti-IL-12 Antibody |
| 03/14/2013 | CA2861150A1 Morphinan derivative |
| 03/14/2013 | CA2848359A1 Cellular uptake control systems |
| 03/13/2013 | EP2567956A1 Novel prenylarene compound and use thereof |
| 03/13/2013 | EP2567955A2 Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 03/13/2013 | EP2567950A1 Substituted alkine derivatives as anti-cancer agents |
| 03/13/2013 | EP2567696A1 Compositions for treating autism spectrum disorder |
| 03/13/2013 | EP2566513A1 Gfi1b modulation and uses thereof |
| 03/13/2013 | CN1981776B Composition containing rare ginseng saponin, its production and usage |
| 03/13/2013 | CN102971318A Tetrahydrocarboline derivative |
| 03/13/2013 | CN102971304A GPR119 agonist |
| 03/13/2013 | CN102971291A Novel amide derivative and use thereof as medicine |
| 03/13/2013 | CN102970993A Use of a composition containing phospholipids and glycyrrhizinic acid for removing subcutaneous fat accumulations by means of subcutaneous lipolysis |
| 03/13/2013 | CN102965372A SiRNA interfering GDF9 gene expression and application thereof |
| 03/13/2013 | CN102964238A Bipolar trans-carotenoid salt and application thereof |
| 03/13/2013 | CN102961719A Medicament for treating intravertebral postanesthesia shivering |
| 03/13/2013 | CN102961682A Traditional Chinese medicine composition for clearing away heat and toxic materials |
| 03/13/2013 | CN102961567A Heat clearing and detoxifying pills |
| 03/13/2013 | CN102961551A Damp clearing composition |
| 03/13/2013 | CN102178756B Oral liquid for treating high altitude disease (HAD) and preparation method thereof |
| 03/13/2013 | CN102056630B Stabilizer for lymph vessel |
| 03/13/2013 | CN102014909B Solid preparation for oral administration |
| 03/13/2013 | CN101980721B Antigendrug excipient comprising synthetic peptide, and mucosal vaccine using the same |
| 03/13/2013 | CN101903045B Pharmaceutical composition for treatment of cataract |
| 03/13/2013 | CN101633636B Peptidomimetic protease inhibitors |
| 03/13/2013 | CN101610767B Combination therapy of substituted oxazolidinones |
| 03/12/2013 | US8394930 Growth factor isoform |
| 03/12/2013 | US8394929 Nogo receptor-mediated blockade of axonal growth |
| 03/12/2013 | US8394628 RNA sequence-specific mediators of RNA interference |
| 03/12/2013 | CA2699568C Azaindoles |
| 03/12/2013 | CA2480199C Fp-ghrelin |